Bryce Harper homers in first at-bat in return to Phillies' lineup after 5 game absence
Associated Press
TORONTO (AP) — With Bryce Harper back in the lineup, the Philadelphia Phillies got off to a booming start against the Toronto Blue Jays.
Harper hit one of two Philadelphia home runs in a six-run first inning off right-hander Bowden Francis in Tuesday's series opener in Toronto.
Harper was back in action after missing five games with a bruised right elbow.
The Phillies went 1-4 without Harper and fell out of first place in the NL East.
Harper followed a two-run home run by Trea Turner with a 394-foot blast, with both homers landing in Philadelphia's right field bullpen.
It was Harper's first at-bat since he was hit by a 95 mph fastball from Atlanta Braves pitcher Spencer Strider during the first inning of a game last week. The home run was his ninth of the season.
Harper's elbow, which underwent Tommy John surgery after the 2022 World Series, remains a sensitive area. In light of the injury, Harper wore a protective guard on his right elbow Tuesday.
Alec Bohm had shifted from third base to first base to replace Harper. Edmundo Sosa had taken over at third. Bohm was back at third base against the Blue Jays. He singled and scored in the first.
___
AP MLB: https://www.apnews.com/hub/MLB
recommended
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hamilton Spectator
12 minutes ago
- Hamilton Spectator
Olympic champ Imane Khelif skips Eindhoven event after World Boxing introduces mandatory sex testing
EINDHOVEN, Netherlands (AP) — Olympic champion Imane Khelif is skipping the Eindhoven Box Cup in the Netherlands less than a week after World Boxing announced mandatory sex testing for all athletes. The Algerian boxer, who won gold at the Paris Games last summer amid scrutiny over her eligibility, did not register in time for the event before applications closed on Thursday. 'The decision of Imane's exclusion is not ours. We regret it,' tournament media director Dirk Renders told The Associated Press. Khelif had intended to return to international competition at the tournament in Hotel Eindhoven before World Boxing announced its new sex testing policy last Friday. Eindhoven mayor Jeroen Dijsselbloem criticized World Boxing's decision. 'As far as we are concerned, all athletes are welcome in Eindhoven. Excluding athletes based on controversial 'gender tests' certainly does not fit in with that,' Dijsselbloem wrote in a letter addressed to the Dutch Boxing Federation and International Boxing Federation. 'We are expressing our disapproval of this decision today and are calling on the organization to admit Imane Khelif after all.' Khelif won a gold medal at the Paris Olympics last summer amid international scrutiny on her and Taiwan's Lin Yu-ting, another gold medal winner. The previous governing body for Olympic boxing, the Russian-dominated International Boxing Association, had disqualified both fighters from its 2023 world championships after claiming they failed unspecified eligibility tests. But the IBA was banished for decades of misdeeds and controversy. The IOC ran the past two Olympic boxing tournaments in its place and it applied the sex eligibility rules used in previous Olympics. Khelif and Lin were eligible to compete under those standards. World Boxing has since been provisionally approved as the boxing organizer at the 2028 Los Angeles Games and has faced pressure from boxers and their federations to create sex eligibility standards. Its president, Boris van der Vorst, apologized after Khelif was singled out in the governing body's announcement last week. Khelif planned to defend her gold medal at the LA Games, but some boxers and their federations have already spoken out against her inclusion. ___ AP boxing:
Associated Press
16 minutes ago
- Associated Press
Who's in charge? CDC's leadership 'crisis' apparent amid new COVID-19 vaccine guidance
WASHINGTON (AP) — There was a notable absence last week when U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced in a 58-second video that the government would no longer endorse the COVID-19 vaccine for healthy children or pregnant women. The director of the Centers for Disease Control and Prevention — the person who typically signs off on federal vaccine recommendations — was nowhere to be seen. The CDC, a $9.2 billion-a-year agency tasked with reviewing life-saving vaccines, monitoring diseases and watching for budding threats to Americans' health, is without a clear leader. 'I've been disappointed that we haven't had an aggressive director since — February, March, April, May — fighting for the resources that CDC needs,' said Dr. Robert Redfield, who served as CDC director under the first Trump administration and supported Kennedy's nomination as the nation's health secretary. $9.2 billion-a-year agency without leader as nomination awaits The leadership vacuum at a foremost federal public health agency has existed for months, after President Donald Trump suddenly withdrew his first pick for CDC director in March. A hearing for his new nominee — the agency's former acting director Susan Monarez — has not been scheduled because she has not submitted all the paperwork necessary to proceed, according to a spokesman for Sen. Bill Cassidy, R-La., who will oversee the nomination. HHS did not answer written questions about Monarez's nomination, her current role at the CDC or her salary. An employee directory lists Monarez, a longtime government employee, as a staffer for the NIH under the Advanced Research Projects Agency for Health. Redfield described Kennedy as 'very supportive' of Monarez's nomination. Instead, a lawyer and political appointee with no medical experience is 'carrying out some of the duties' of director at the agency that for seven decades has been led by someone with a medical degree. Matthew Buzzelli, who is also the chief of staff at the CDC, is 'surrounded by highly qualified medical professionals and advisors to help fulfill these duties as appropriate,' Andrew Nixon, an HHS spokesperson said in a statement. Adding to the confusion was an employee-wide email sent last week that thanked 'new acting directors who shave stepped up to the plate.' The email, signed by Monarez, listed her as the acting director. It was was sent just days after Kennedy said at a Senate hearing that Monarez had been replaced by Buzzelli. The lack of a confirmed director will be a problem if a public health emergency such as the COVID-19 pandemic or a rapid uptick in measles cases hits, said Michael Osterholm, an epidemiologist at the University of Minnesota. 'CDC is a crisis, waiting for a crisis to happen,' said Osterholm. 'At this point, I couldn't tell you for the life of me who was going to pull what trigger in a crisis situation.' An acting director rarely seen, and stalled decisions At CDC headquarters in Atlanta, employees say Monarez was rarely heard from between late January – when she was appointed acting director – and late March, when Trump nominated her. She also has not held any of the 'all hands' meetings that were customary under previous CDC chiefs, according to several staffers. One employee, who insisted on anonymity because they were not authorized to speak to the media and fears being fired if identified said Monarez has been almost invisible since her nomination, adding that her absence has been cited by other leaders as an excuse for delaying action. The situation already has led to confusion. In April, a 15-member CDC advisory panel of outside experts met to discuss vaccine policy. The panel makes recommendations to the CDC Director, who routinely signs off on them. But it was unclear during the meeting who would be reviewing the panel's recommendations, which included the expansion of RSV vaccinations for adults and a new combination shot as another option to protect teens against meningitis. HHS officials said the recommendations were going to Buzzelli, but then weeks passed with no decision. A month after the meeting ended, the CDC posted on a web site that Kennedy had signed off on recommendations for travelers against chikungunya, a viral disease transmitted to humans by mosquitos. But there continues to be no word about a decision about the other vaccine recommendations. Controversial COVID-19 vaccine recommendations bypassed CDC panel The problem was accentuated again last week, when Kennedy rolled out recommendations for the COVID-19 vaccine saying they were no longer recommended for healthy children or pregnant women, even though expectant mothers are considered a high-risk group if they contract the virus. Kennedy made the surprise announcement without input from the CDC advisory panel that has historically made recommendations on the nation's vaccine schedule. The CDC days later posted revised guidance that said healthy kids and pregnant women may get the shots. Nixon, the HHS spokesman, said CDC staff were consulted on the recommendations, but would not provide staffer's names or titles. He also did not provide the specific data or research that Kennedy reviewed to reach his conclusion on the new COVID-19 recommendations, just weeks after he said that he did not think 'people should be taking medical advice' from him. 'As Secretary Kennedy said, there is a clear lack of data to support the repeat booster strategy in children,' Nixon said in a statement. Research shows that pregnant women are at higher risk of severe illness, mechanical ventilation and death, when they contract COVID-19 infections. During the height of the pandemic, deaths of women during pregnancy or shortly after childbirth soared to their highest level in 50 years. Vaccinations also have been recommended for pregnant women because it passes immunity to newborns who are too young for vaccines and also vulnerable to infections. Nixon did not address a written question about recommendations for pregnant women. Kennedy's decision to bypass the the advisory panel and announce new COVID-19 recommendations on his own prompted a key CDC official who works with the committee – Dr. Lakshmi Panagiotakopoulos – to announce her resignation last Friday. 'My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,' she wrote in an email seen by an Associated Press reporter. Signs are mounting that the CDC has been 'sidelined' from key decision-making under Kennedy's watch, said Dr. Anand Parekh, the chief medical adviser for The Bipartisan Policy Center. 'It's difficult to ascertain how we will reverse the chronic disease epidemic or be prepared for myriad public health emergencies without a strong CDC and visible, empowered director,' Parekh said. 'It's also worth noting that every community in the country is served by a local or state public health department that depends on the scientific expertise of the CDC and the leadership of the CDC director.'
Forbes
19 minutes ago
- Forbes
Jerry Reinsdorf Reaches Framework For Sale Of White Sox To Justin Ishbia
The White Sox announced today that a deal is in place for Justin Ishbia to purchase a controlling interest in the Chicago White Sox gradually. The long-term investment agreement would see Ishbia make capital infusions into the White Sox as a limited partner in 2025 and 2026 that will be used to pay down existing debt and support ongoing team operations. After that, the dynamic would change. While the gap after 2026 is not detailed, from 2029 to 2033, Reinsdorf will have the option to sell the controlling interest to Ishbia. After the 2034 season, Ishbia will have the option to acquire the controlling interest in the White Sox. The statement by the club goes on to say that should any such future transaction occur, all limited partners of the Sox would have the opportunity to sell to Ishbia at that time. Justin Ishbia would also see his brother, Mat, and father, Jeff, as 'significant investors.' Financial details were not revealed. The escalation path would cap another key sports holding by Justin Ishbia, who in 2023 purchased the majority stake in the NBA's Phoenix Suns and the WNBA's Phoenix Mercury for a then-record $4 billion. He also owns a minority stake in Major League Soccer's Nashville SC. Forbes currently shows Ishbia's net worth at $4.3 billion. The announcement comes at a critical time for the White Sox, who last year set a Major League modern era record for losses with a record of 41-121. According to Sportrac, the White Sox have a player payroll of $ 67,851,036, ranking them 28th, behind only the A's ($75,317,644) and the Miami Marlins ($66,840,425) for the lowest in all of Major League Baseball. The most recent valuation by Forbes shows the White Sox valued at $2 billion, ranking them 16th of 20. Reinsdorf has also sought to get a new ballpark built for the White Sox. Currently the lease on Rate Field expires in October of 2029. The Ishbias would now play a critical factor in that effort. Jerry Reinsdorf and Eddie Einhorn purchased the White Sox for $19 million in 1981 after MLB's owners rejected a sale from Bill Veeck to Ed DeBartolo. Since Reinsdorf purchased the club, the White Sox have made the playoffs five times, winning the World Series in 2005, their first since 1917.
